Heron Therapeutics Inc (HRTX)

03:36 AM

Heron Therapeutics (NASDAQ:HRTX) Share Price Crosses Above 200 Day Moving AverageHere's What Happened - MarketBeat

03:36 AM

Feb 06, 2025

An analyst sees good growth prospects for Heron Therapeutics Inc (HRTX) - SETE News

Feb 06, 2025

Feb 04, 2025

Financial Metrics Check: Heron Therapeutics Inc (HRTX)’s Ratios for Trailing Twelve Months - The Dwinnex

Feb 04, 2025

Feb 04, 2025

Are Heron Therapeutics Inc (HRTX) shares a good deal now? - US Post News

Feb 04, 2025

Feb 02, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Purchased by JPMorgan Chase & Co. - MarketBeat

Feb 02, 2025

Feb 01, 2025

StockNews.com Downgrades Heron Therapeutics (NASDAQ:HRTX) to Hold - MarketBeat

Feb 01, 2025

Jan 30, 2025

JPMorgan Chase & Co. Has $411,000 Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Jan 30, 2025

Jan 29, 2025

Heron Therapeutics (NASDAQ:HRTX) Stock Rating Lowered by StockNews.com - Defense World

Jan 29, 2025

Jan 24, 2025

HRTX’s Market Whiplash: 15.03% YTD Rise, 15.03% Rise in 30 Days - The InvestChronicle

Jan 24, 2025

Jan 21, 2025

Great week for Heron Therapeutics, Inc. (NASDAQ:HRTX) institutional investors after losing 26% over the previous year - Simply Wall St

Jan 21, 2025

Jan 21, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) is a favorite amongst institutional investors who own 58% - Yahoo Finance

Jan 21, 2025

Jan 21, 2025

Heron Therapeutics (NASDAQ:HRTX) Upgraded by StockNews.com to Buy Rating - MarketBeat

Jan 21, 2025

Jan 21, 2025

Heron Therapeutics (NASDAQ:HRTX) Upgraded to Buy at StockNews.com - Defense World

Jan 21, 2025

Jan 19, 2025

Barclays PLC Purchases 50,109 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Jan 19, 2025

Jan 17, 2025

Congress Park Capital LLC Grows Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

Jan 17, 2025

Jan 14, 2025

Heron Therapeutics (NASDAQ:HRTX) Downgraded by StockNews.com to Hold - Defense World

Jan 14, 2025

Jan 13, 2025

Heron Therapeutics (NASDAQ:HRTX) Downgraded to "Hold" Rating by StockNews.com - MarketBeat

Jan 13, 2025

Jan 10, 2025

San Diego Biotech Firm Heron Therapeutics Shifts Operations to North Carolina - MSN

Jan 10, 2025

Jan 07, 2025

Principal Financial Group Inc. Raises Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Jan 07, 2025

Jan 04, 2025

Geode Capital Management LLC Sells 66,974 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Jan 04, 2025

Jan 04, 2025

Jane Street Group LLC Cuts Stock Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Jan 04, 2025

Jan 03, 2025

Franklin Resources Inc. Sells 6,304,716 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Jan 03, 2025

Jan 03, 2025

Franklin Resources Inc. Decreases Stock Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

Jan 03, 2025

Jan 01, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Short Interest Update - MarketBeat

Jan 01, 2025

Dec 31, 2024

Heron Therapeutics (NASDAQ:HRTX) Rating Lowered to “Hold” at StockNews.com - Defense World

Dec 31, 2024

Dec 31, 2024

This San Diego biotech is moving its HQ to North Carolina - The San Diego Union-Tribune

Dec 31, 2024

Dec 29, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by State Street Corp - MarketBeat

Dec 29, 2024

Dec 28, 2024

Heron Therapeutics to Shift Headquarters from San Diego to Cary, - Hoodline

Dec 28, 2024

Dec 26, 2024

California public company relocates to North Carolina - The Business Journals

Dec 26, 2024

Dec 23, 2024

Heron Therapeutics Relocates Headquarters to North Carolina - TipRanks

Dec 23, 2024

Dec 23, 2024

Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina - PR Newswire

Dec 23, 2024

Dec 19, 2024

Heron Therapeutics (NASDAQ:HRTX) Cut to "Hold" at StockNews.com - MarketBeat

Dec 19, 2024

Dec 18, 2024

Fmr LLC Has $859,000 Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Dec 18, 2024

Dec 16, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Bought by Verition Fund Management LLC - Defense World

Dec 16, 2024

Dec 16, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Stake Lowered by Charles Schwab Investment Management Inc. - Defense World

Dec 16, 2024

Dec 12, 2024

U.S. District Court Upholds Validity of CINVANTI® Patents - The Eastern Progress Online

Dec 12, 2024

Dec 11, 2024

Exploring Three High Growth Tech Stocks In The United States - Yahoo Finance

Dec 11, 2024

Dec 11, 2024

Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business Officer - The Eastern Progress Online

Dec 11, 2024

Dec 11, 2024

StockNews.com Upgrades Heron Therapeutics (NASDAQ:HRTX) to "Buy" - MarketBeat

Dec 11, 2024

Dec 11, 2024

Heron Therapeutics (NASDAQ:HRTX) Rating Increased to Buy at StockNews.com - Defense World

Dec 11, 2024

Dec 08, 2024

Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance - Kilgore News Herald

Dec 08, 2024

Dec 07, 2024

Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors - The Eastern Progress Online

Dec 07, 2024